SE9900043D0 - New use - Google Patents

New use

Info

Publication number
SE9900043D0
SE9900043D0 SE9900043A SE9900043A SE9900043D0 SE 9900043 D0 SE9900043 D0 SE 9900043D0 SE 9900043 A SE9900043 A SE 9900043A SE 9900043 A SE9900043 A SE 9900043A SE 9900043 D0 SE9900043 D0 SE 9900043D0
Authority
SE
Sweden
Prior art keywords
treatment
molecular weight
low molecular
new use
dialysing
Prior art date
Application number
SE9900043A
Other languages
English (en)
Swedish (sv)
Inventor
Gunnar Fager
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9900043A priority Critical patent/SE9900043D0/xx
Publication of SE9900043D0 publication Critical patent/SE9900043D0/xx
Priority to CNB008026963A priority patent/CN100387296C/zh
Priority to ES00901367T priority patent/ES2255968T3/es
Priority to BR0007448-9A priority patent/BR0007448A/pt
Priority to EP00901367A priority patent/EP1144000B1/en
Priority to DE60025698T priority patent/DE60025698T2/de
Priority to NZ512712A priority patent/NZ512712A/en
Priority to IL14382400A priority patent/IL143824A0/xx
Priority to PCT/SE2000/000030 priority patent/WO2000041715A1/en
Priority to CA002356440A priority patent/CA2356440A1/en
Priority to KR1020017008703A priority patent/KR100840452B1/ko
Priority to AT00901367T priority patent/ATE316384T1/de
Priority to JP2000593325A priority patent/JP4054533B2/ja
Priority to AU21409/00A priority patent/AU763185B2/en
Priority to DK00901367T priority patent/DK1144000T3/da
Priority to SI200030825T priority patent/SI1144000T1/sl
Priority to ZA200105274A priority patent/ZA200105274B/en
Priority to NO20013301A priority patent/NO326996B1/no
Priority to US10/098,625 priority patent/US20030042202A1/en
Priority to US11/074,893 priority patent/US20050153904A1/en
Priority to CY20061100544T priority patent/CY1107461T1/el
Priority to US11/878,881 priority patent/US20080004225A1/en
Priority to US12/222,604 priority patent/US20090192137A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424—Substitution fluid path
    • A61M1/3427—Substitution fluid path back through the membrane, e.g. by inverted trans-membrane pressure [TMP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
SE9900043A 1993-06-03 1999-01-11 New use SE9900043D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9900043A SE9900043D0 (sv) 1999-01-11 1999-01-11 New use
SI200030825T SI1144000T1 (sl) 1999-01-11 2000-01-11 Nova dializna metoda
KR1020017008703A KR100840452B1 (ko) 1999-01-11 2000-01-11 신규한 투석 방법
JP2000593325A JP4054533B2 (ja) 1999-01-11 2000-01-11 新規透析法
BR0007448-9A BR0007448A (pt) 1999-01-11 2000-01-11 Uso de um inibidor de trombina de baixo peso molecular, solução de diálise, concentrado de diálise, kit de partes para uso em diálise, processo para a preparação de uma solução, ou de um concentrado, e, método de tratamento por diálise de um paciente necessitando de tal tratamento
EP00901367A EP1144000B1 (en) 1999-01-11 2000-01-11 New dialysis method
DE60025698T DE60025698T2 (de) 1999-01-11 2000-01-11 Neue dialysemethode
NZ512712A NZ512712A (en) 1999-01-11 2000-01-11 New dialysis method using low molecular weight thrombin inhibitors
IL14382400A IL143824A0 (en) 1999-01-11 2000-01-11 New dialysis method
PCT/SE2000/000030 WO2000041715A1 (en) 1999-01-11 2000-01-11 New dialysis method
CA002356440A CA2356440A1 (en) 1999-01-11 2000-01-11 New dialysis method
CNB008026963A CN100387296C (zh) 1999-01-11 2000-01-11 新透析法
AT00901367T ATE316384T1 (de) 1999-01-11 2000-01-11 Neue dialysemethode
ES00901367T ES2255968T3 (es) 1999-01-11 2000-01-11 Nuevo metodo de dialisis.
AU21409/00A AU763185B2 (en) 1999-01-11 2000-01-11 New dialysis method
DK00901367T DK1144000T3 (da) 1999-01-11 2000-01-11 Ny fremgangsmåde til dialyse
ZA200105274A ZA200105274B (en) 1999-01-11 2001-06-26 New dialysis method.
NO20013301A NO326996B1 (no) 1999-01-11 2001-07-03 Anvendelse av trombininhibitor for fremstilling av et medikament for dialysebehandling.
US10/098,625 US20030042202A1 (en) 1999-01-11 2002-03-18 Dialysis method
US11/074,893 US20050153904A1 (en) 1999-01-11 2005-03-09 Dialysis method
CY20061100544T CY1107461T1 (el) 1999-01-11 2006-04-19 Νεα μεθοδος διαπιδυσης
US11/878,881 US20080004225A1 (en) 1999-01-11 2007-07-27 New dialysis method
US12/222,604 US20090192137A1 (en) 1993-06-03 2008-08-12 Dialysis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900043A SE9900043D0 (sv) 1999-01-11 1999-01-11 New use

Publications (1)

Publication Number Publication Date
SE9900043D0 true SE9900043D0 (sv) 1999-01-11

Family

ID=20414050

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900043A SE9900043D0 (sv) 1993-06-03 1999-01-11 New use

Country Status (19)

Country Link
US (4) US20030042202A1 (zh)
EP (1) EP1144000B1 (zh)
JP (1) JP4054533B2 (zh)
KR (1) KR100840452B1 (zh)
CN (1) CN100387296C (zh)
AT (1) ATE316384T1 (zh)
AU (1) AU763185B2 (zh)
BR (1) BR0007448A (zh)
CA (1) CA2356440A1 (zh)
CY (1) CY1107461T1 (zh)
DE (1) DE60025698T2 (zh)
DK (1) DK1144000T3 (zh)
ES (1) ES2255968T3 (zh)
IL (1) IL143824A0 (zh)
NO (1) NO326996B1 (zh)
NZ (1) NZ512712A (zh)
SE (1) SE9900043D0 (zh)
WO (1) WO2000041715A1 (zh)
ZA (1) ZA200105274B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1466916B1 (en) 2002-09-09 2007-10-24 Trigen Limited Peptide boronic acids useful in making salts thereof
US7112572B2 (en) 2002-09-09 2006-09-26 Trigen Limited Multivalent metal salts of boronic acids
US7235589B2 (en) * 2004-09-21 2007-06-26 Bio Numerik Pharmaceuticals, Inc. Method of treating patients undergoing kidney dialysis
CN105115949B (zh) * 2005-12-21 2018-06-22 梅索斯卡莱科技公司 分析装置、方法和试剂
CA3122671A1 (en) 2005-12-21 2008-05-15 Meso Scale Technologies, Llc. Assay apparatuses, methods and reagents
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
ES2647775T3 (es) * 2011-08-02 2017-12-26 Medtronic, Inc. Sistema de hemodiálisis que tiene una trayectoria de flujo con un volumen distensible controlado
US9623164B2 (en) 2013-02-01 2017-04-18 Medtronic, Inc. Systems and methods for multifunctional volumetric fluid control
US10010663B2 (en) 2013-02-01 2018-07-03 Medtronic, Inc. Fluid circuit for delivery of renal replacement therapies
US10850016B2 (en) 2013-02-01 2020-12-01 Medtronic, Inc. Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection
US10874787B2 (en) 2014-12-10 2020-12-29 Medtronic, Inc. Degassing system for dialysis
US9713665B2 (en) 2014-12-10 2017-07-25 Medtronic, Inc. Degassing system for dialysis
US10098993B2 (en) 2014-12-10 2018-10-16 Medtronic, Inc. Sensing and storage system for fluid balance
US11278654B2 (en) 2017-12-07 2022-03-22 Medtronic, Inc. Pneumatic manifold for a dialysis system
US11033667B2 (en) 2018-02-02 2021-06-15 Medtronic, Inc. Sorbent manifold for a dialysis system
US11110215B2 (en) 2018-02-23 2021-09-07 Medtronic, Inc. Degasser and vent manifolds for dialysis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
US4489535A (en) * 1980-10-02 1984-12-25 Veltman Preston Leonard Materials and method for preparing dialysis solutions containing bicarbonate ions
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US5380299A (en) * 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
DE4443390A1 (de) * 1994-12-06 1996-06-13 Basf Ag Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
KR19980702112A (ko) * 1995-02-10 1998-07-15 페라 스타르크,요헨 카르크 트롬빈 억제제
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
CZ291690B6 (cs) * 1996-02-13 2003-05-14 Akzo Nobel N. V. Inhibitory serinové proteázy a farmaceutický prostředek
EP0884325A1 (en) * 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
CA2288224A1 (en) * 1997-04-30 1998-11-05 Mary George Johnson Antithrombotic agents
AU7270798A (en) * 1997-05-01 1998-11-24 Eli Lilly And Company Antithrombotic agents
WO1998050420A1 (en) * 1997-05-02 1998-11-12 Akzo Nobel N.V. Serine protease inhibitors

Also Published As

Publication number Publication date
US20050153904A1 (en) 2005-07-14
EP1144000A1 (en) 2001-10-17
BR0007448A (pt) 2001-10-16
EP1144000B1 (en) 2006-01-25
CN1354673A (zh) 2002-06-19
AU2140900A (en) 2000-08-01
IL143824A0 (en) 2002-04-21
US20090192137A1 (en) 2009-07-30
KR100840452B1 (ko) 2008-06-20
US20030042202A1 (en) 2003-03-06
US20080004225A1 (en) 2008-01-03
JP2002534217A (ja) 2002-10-15
AU763185B2 (en) 2003-07-17
JP4054533B2 (ja) 2008-02-27
NZ512712A (en) 2004-09-24
ES2255968T3 (es) 2006-07-16
NO20013301D0 (no) 2001-07-03
NO20013301L (no) 2001-07-03
NO326996B1 (no) 2009-03-30
WO2000041715A1 (en) 2000-07-20
ATE316384T1 (de) 2006-02-15
CA2356440A1 (en) 2000-07-20
CY1107461T1 (el) 2012-12-19
DE60025698T2 (de) 2006-10-19
ZA200105274B (en) 2002-09-26
CN100387296C (zh) 2008-05-14
DE60025698D1 (de) 2006-04-13
KR20010093250A (ko) 2001-10-27
DK1144000T3 (da) 2006-05-08

Similar Documents

Publication Publication Date Title
CY1107461T1 (el) Νεα μεθοδος διαπιδυσης
SE9702860L (sv) Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
AR042795A1 (es) Fluidos de dialisis biocompatibles que contienen icodextrinas
DK1218039T3 (da) Anvendelse af dialysat med höjt citratindhold
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
EA200400548A1 (ru) Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
CY1105068T1 (el) ΈΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ ΓΙΑ Xa
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
MY125984A (en) Pharmaceutical solutions of levosimendan.
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE60018569D1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
DK1509231T3 (da) System til peritonealdialyse omfattende et reservoir til dialyseopløsning og en patron, der indeholder taurolidinpulver
SE0001939D0 (sv) Medical solution and use thereof
EA199900609A1 (ru) Способ и фармацевтическая композиция для доставки железа у пациентов, получающих гемодиализ и перитонеальный диализ
EP1847527A4 (en) NEW BENZAMIDINE DERIVATIVE
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
NZ514911A (en) Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
SE0301577L (sv) Lösning med låg natriumhalt
DE60237821D1 (de) Antibakterielle behandlung von osteoarthritis
SE0203349D0 (sv) New use
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
GB0007239D0 (en) Use
DE60235965D1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz